Fanconi-Bickel syndrome: genes and variants
Explore variant evidence for Fanconi-Bickel syndrome across 1 analyzed protein (SLC2A2). Linked ClinVar records include 10 pathogenic or likely pathogenic variants, 75 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Fanconi-Bickel syndrome
SLC2A2: Solute carrier family 2, facilitated glucose transporter member 2
It enables high-capacity bidirectional glucose transport in liver, intestine, kidney, and pancreatic cells, matching transport to changing glucose concentrations. Biallelic loss-of-function variants cause Fanconi-Bickel syndrome with hepatomegaly, abnormal glucose homeostasis, and renal tubular dysfunction.
10 ClinVar pathogenic / likely pathogenic and 82 uncertain variants in SLC2A2 have source records linked to Fanconi-Bickel syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Fanconi-Bickel syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SLC2A2 R158S | 158 | Extracellular | Pathogenic / likely pathogenic (★★) |
| SLC2A2 V197L | 197 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A2 P417L | 417 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| SLC2A2 G318R | 318 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A2 G416S | 416 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A2 W444R | 444 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A2 M1R | 1 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| SLC2A2 G20D | 20 | Transmembrane | Pathogenic / likely pathogenic (★) |
| SLC2A2 V423E | 423 | Cytoplasmic | Pathogenic / likely pathogenic |
| SLC2A2 L389P | 389 | Transmembrane | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Fanconi-Bickel syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| SLC2A2 P417Q | 417 | Transmembrane | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; P417L at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.755 |
Diseases related to Fanconi-Bickel syndrome
- Monogenic diabetes, also linked to SLC2A2
- Type 2 diabetes mellitus, also linked to SLC2A2
Frequently asked questions
Which genes have records linked to Fanconi-Bickel syndrome?
This view contains 1 analyzed proteins: SLC2A2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 10 pathogenic or likely pathogenic variants, 75 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 1 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 109 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center